Advertisement

September 2017 Briefing – Dermatology

0
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for September 2017. This roundup includes the latest...
Secukinumab is safe and effective as a treatment for patients with extensive moderate-to-severe scalp psoriasis

Secukinumab Effective for Moderate/Severe Scalp Psoriasis

0
Over half of patients have 90 percent improvement on Psoriasis Scalp Severity Index score
Among physicians posting top plastic surgery-related content to Instagram

Certified Plastic Surgeons Underrepresented on Instagram

0
Most posts associated with 21 plastic surgery-related hashtags on Instagram are self-promotional
Embezzlement is widespread among medical practices

Embezzlement Widespread in Medical Practices

0
Red flags include employee being secretive about their work, working late, not wanting to share tasks
Treatment of the buccinator with botulinum toxin is safe and effective

Treatment of Buccinator With Botox Is Safe, Effective

0
And three commercially available botulinum toxin treatments are similar for facial synkinesis
More than 78 percent of health care personnel and 53.6 percent of pregnant women received influenza vaccination during the 2016-2017 influenza season

More Than 78 Percent of Health Care Personnel Receive Flu Shot

0
But only 53.6 percent of pregnant women received flu shot before/during pregnancy in 2016-2017
For patients with melanoma

Propranolol Use Inversely Linked to Melanoma Recurrence

0
Patients taking propranolol as off-label adjuvant treatment had reduced risk of recurrence
Working with a scribe significantly improves physicians' overall satisfaction

Working With a Scribe Improves Physician Satisfaction

0
When scribes draft documents, physicians happier with chart quality and accuracy, time with patients
Routine use of systemic corticosteroids is generally discouraged for atopic dermatitis

Systemic Corticosteroids Discouraged for Atopic Dermatitis

0
Systemic corticosteroids should generally be avoided, but can be used in specific circumstances
Bacillus Calmette-Guérin vaccination within seven days of birth may reduce the risk of allergic diseases

Bacillus Calmette-Guérin Vaccine May Reduce Atopic Dermatitis

0
Findings among newborns vaccinated within seven days of birth